Literature DB >> 4589325

Suppression of cellular immunity in vivo by rifampicin.

G L Floersheim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4589325     DOI: 10.1007/bf01943909

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  7 in total

1.  Immunosuppressive effect of rifampicin.

Authors:  B Serrou; C Solassol; H Joyeux; H Pujol; C Romieu
Journal:  Transplantation       Date:  1972-11       Impact factor: 4.939

2.  Rifampicin: an immunosuppressant?

Authors:  B S Nilsson
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

3.  De-novo brain tumours in renal-transplant recipients.

Authors:  S A Schneck; I Penn
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

4.  Antagonistic effects to phalloidin, alpha-amanitin and extracts of Amanita phalloides.

Authors:  G L Floersheim
Journal:  Agents Actions       Date:  1971-11

5.  In vivo and in vitro suppression of humoral and cellular immunological response by rifampicin.

Authors:  E Păunescu
Journal:  Nature       Date:  1970-12-19       Impact factor: 49.962

6.  [Pharmacological susceptibility of cellular immunity].

Authors:  G L Floersheim
Journal:  Z Naturwiss Med Grundlagenforsch       Date:  1965-10

7.  Skin cancer and immunosuppression.

Authors:  B K Walder; M R Robertson; D Jeremy
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

  7 in total
  1 in total

1.  Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of Mycobacterium tuberculosis.

Authors:  Susanta Pahari; Shikha Negi; Mohammad Aqdas; Eusondia Arnett; Larry S Schlesinger; Javed N Agrewala
Journal:  Autophagy       Date:  2019-09-08       Impact factor: 16.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.